Analyst Just Declared Lilly the Clear Winner at ADA Conference
The ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
This introductory paragraph highlights how yearly drawdown data for index funds reveals cyclic risk patterns and guides more resilient investment choices.
25,260 articlesThe ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
AI's rise depends not only on chips and servers but on the cooling and mechanical systems that keep data centers aliv...
Oklo is developing compact nuclear reactors geared for AI data centers. This article lays out a grounded five-year ro...
As driverless taxis move from test zones to real streets, Alphabet and its Waymo unit sit at the center of the race. ...
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
A broad coalition asks federal regulators to review Compass International Holdings’ data-sharing agreements with mult...
Two tech giants are racing to dominate AI. This guide breaks down why Alphabet and Amazon could be the better artific...
Sanofi is accelerating its internal AI push with a home grown assistant and a centralized data lake. The strategy aim...
A surge in AI workloads hinges on memory, and Micron’s latest signals hint at lasting strength. This piece unpacks wh...
A new alliance between Shopify and Google AI is reshaping e-commerce search and discovery. This analysis breaks down ...
The (nrxp) 2026 earnings call highlights a shifting biotech landscape. This article breaks down what the results mean...